Microneedle-Based Generation of Microbubbles in Cancer Tumors to Improve Ultrasound-Assisted Drug Delivery.
Ashkan ZandiMohammad Ali KhayamianMohammad SaghafiShahriar ShalilehPouyan KatebiSepanta AssadiAli GilaniMohammad Salemizadeh PariziShohreh VanaeiMohammad Reza EsmailinejadFereshteh AbbasvandiParisa HoseinpourMohammad AbdolahadPublished in: Advanced healthcare materials (2019)
Production of local microbubbles (MBs) with dense distribution in tumor environment is achieved by developing an integrated electrochemical stimulator on a microfabricated silicon needle covered by zinc-oxide nanowires (ZnONWs). MBs are then exploded by external ultrasonic actuation, which induce microcavitations in tumor cells followed by direct entrance of anticancer drugs into cancer cells. This system, named ZnO nanowire-based microbubble generator probe (ZnONW-MGP), is tested on tumorized mice models (by MC4L2 breast cell lines). Mice treated by ZnONW-MGP have ≈82% reduction in tumor size within 10 days with just 25% of conventional dose of paclitaxel while in the absence of the system, they have just a 15% reduction in tumor size. Presence of ZnO nanostructures on microneedles strongly reduces the size of MBs and enhances the efficacy of the sonoporation.
Keyphrases
- room temperature
- drug delivery
- quantum dots
- reduced graphene oxide
- high fat diet induced
- gold nanoparticles
- papillary thyroid
- metabolic syndrome
- young adults
- living cells
- insulin resistance
- high resolution
- lymph node metastasis
- drug induced
- molecularly imprinted
- visible light
- childhood cancer
- wild type
- tandem mass spectrometry